Skip to main content
SpringerLink
Log in

Alectinib/ceritinib/crizotinib

High ALT, high CK-MB and drug resistance: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zhang Y, et al. Case Report: A Case Report of a Histological Transformation of ALK-Rearranged Adenocarcinoma With High Expression of PD-L1 to Squamous Cell Carcinoma After Treatment With Alectinib. Pathology Oncology Research 27: 1-6, 01 Apr 2021. Available from: URL: http://doi.org/10.3389/pore.2021.637745

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib/ceritinib/crizotinib. Reactions Weekly 1891, 17 (2022). https://doi.org/10.1007/s40278-022-09269-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09269-6

Search

Navigation